Cara Therapeutics reported $203.47M in Equity Capital and Reserves for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 564.84M 16.77M
Acelrx Pharmaceuticals ACRX:US $ -35.99M 8.68M
Aerie Pharmaceuticals AERI:US $ -39.61M 29.25M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
Biodelivery Sciences International BDSI:US $ 113.92M 5.06M
Cara Therapeutics CARA:US $ 203.47M 26.99M
Chugai Pharma 4519:JP Y 1052058M 69450M
Depomed DEPO:US $ 92.26M 13.04M
Endo International Ordinary Shares ENDP:US $ -617.04M 18.07M
Halozyme Therapeutics HALO:US $ 119.75M 52.15M
Horizon Pharma HZNP:US $ 4073.64M 218.87M
JAZZ PHA JAZZ:US $ 4131.49M 333.8M
Neurocrine Biosciences NBIX:US $ 1279.2M 73.6M
Pacira Pharmaceuticals PCRX:US $ 687.17M 36.35M
Pain Therapeutics PTIE:US $ 276.48M 4.71M
Redhill Biopharma RDHL:US $ 29.58M 23.46M
Revance Therapeutics RVNC:US $ 186.24M 58.01M
Supernus Pharmaceuticals SUPN:US $ 785.58M 31.14M
Teva Pharmaceutical Industries TEVA:US $ 10324M 324M
Vanda Pharmaceuticals VNDA:US $ 481.22M 13.59M